Cantor Fitzgerald
Olivia Brayer is a seasoned professional in the biotechnology sector, currently serving as Director and Senior Biotech Analyst at Cantor Fitzgerald since April 2022. Prior experience includes the role of Vice President in Equity Research at Bank of America from 2019 to 2022, where Olivia was part of a top-ranked Large Cap Biotech team. Prior to that, positions held at Barclays and Guggenheim Partners involved covering US Pharma and Biotech sectors, with a focus on immuno-oncology at Guggenheim. Olivia holds a Bachelor of Arts in Mathematics and French from Amherst College and completed a study abroad program at Université Paris-Sorbonne.
This person is not in the org chart
This person is not in any offices
Cantor Fitzgerald
20 followers
Cantor Fitzgerald is a leading global financial services firm, serving clients from over 30 offices around the world. Founded in 1945 as a securities brokerage and investment bank, the firm pioneered computer-based bond trading, built one of the broadest distribution networks in the industry and became the market’s premier dealer of government securities.